Your AI-Trained Oncology Knowledge Connection!
Video
Author(s):
Closing thoughts from a panel of ALL experts on improving access to therapy and how their field may evolve in years to come.
May 14th 2025 - Jun 19th 2025
May 14th 2025 - Jun 19th 2025
May 14th 2025 - May 15th 2026
May 15th 2025 - May 16th 2026
May 15th 2025 - May 16th 2026
May 14th 2025 - Jun 19th 2025
May 14th 2025 - Jun 19th 2025
May 14th 2025 - May 15th 2026
May 15th 2025 - May 16th 2026
May 15th 2025 - May 16th 2026
May 14th 2025 - Jun 19th 2025
May 14th 2025 - Jun 19th 2025
May 14th 2025 - May 15th 2026
T-DM1 Plus Palbociclib Displays Activity in HER2+ Metastatic Breast Cancer
EL1SSAR Data Shed Light on Leveraging Atezolizumab Plus Nab-Paclitaxel in PD-L1+ TNBC
Pretreatment ctDNA Status Is Associated With Distant Recurrent-Free Survival in Early Breast Cancer
Zanidatamab/Chemotherapy Yields Responses and Is Safe in HER2-Expressing Metastatic Breast Cancer
2 Commerce Drive
Cranbury, NJ 08512